# Accuray Incorporated (ARAY)

> Source: Nexqual · https://nexqual.com/ARAY · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Accuray Incorporated (ARAY), nexqual.com/ARAY" · informational, not investment advice.

**Price:** USD 0.17 (-0.74% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 0.18 · day 0.16–0.18 · 52w 0.16–1.79 · market cap $20.8M · NCM

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $402M, net income -$49.2M (-12.2% margin), free cash flow -$12.8M (SEC filings).
- Analysts: Hold (mean 3.00 on a 1–5 scale) (1 analysts).
- Total return with dividends: 1Y -90.3% vs S&P 500 +18.1%; 5Y -95.6% vs S&P 500 +85.1%.
- Next earnings: 2026-11-04, EPS estimate USD —, revenue estimate $0K.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $430M | $448M | $447M | $459M | $402M | $402M |
| Gross profit | $160M | $154M | $143M | $147M | $111M | — |
| Operating income | $8.1M | $2.4M | $504K | $7.8M | -$26.4M | -$26.4M |
| Net income | -$5.3M | -$9.3M | -$15.5M | -$1.6M | -$49.2M | -$49.2M |
| EPS (diluted) | -$0.06 | -$0.10 | -$0.16 | -$0.02 | — | — |
| Free cash flow | -$7.1M | $2.9M | -$15.5M | -$1.4M | -$12.8M | -$12.8M |
| Gross margin | 37.2% | 34.4% | 32.0% | 32.1% | 27.7% | — |
| Operating margin | 1.9% | 0.5% | 0.1% | 1.7% | -6.6% | -6.6% |
| Net margin | -1.2% | -2.1% | -3.5% | -0.3% | -12.2% | -12.2% |
| Revenue growth | +8.5% | +4.1% | -0.2% | +2.7% | -12.3% | — |
| Cash + short-term investments | $88.7M | $89.4M | $68.6M | $57.4M | $40.6M | — |
| Total debt | $180M | $177M | $172M | $137M | $148M | — |
Fiscal years end Jun. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/S 0.1x · EV/Sales 0.3x · P/B 0.5x · FCF yield -61.86% · Earnings yield -236.98% · Net debt $107M · EV $128M

## Analysts
Consensus Hold (mean 3.00 on a 1–5 scale), 1 analysts.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -90.3% | -95.6% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -90.4% | -46.3% |
| Volatility (annualized) | 115.7% | 69.8% |
| Max drawdown | -90.3% (Oct 2025→Oct 2026) | -97.1% (Nov 2021→Oct 2026) |

## Peers (Medical Devices)
ESTA (Establishment Labs Holdings Inc) USD 61.36 +4.98% · ALMR (Alamar Biosciences, Inc.) USD 27.42 +16.58% · INSP (Inspire Medical Systems, Inc.) USD 70.12 +1.83% · BFLY (Butterfly Network, Inc.) USD 7.85 -3.09% · AXGN (AxoGen, Inc.) USD 35.63 -1.49% · UFPT (UFP Technologies, Inc.) USD 297.19 +0.99%

## More
Full page: https://nexqual.com/ARAY · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt